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Neutrophil-lymphocyte ratio: Can clinicians  
really trust it as an inflammatory indicator?
We have read the article ‘Neutrophil to lym-
phocyte ratio (NLR) predicts short- and long-term 
mortality following revascularization therapy for 
ST elevation myocardial infarction (STEMI)’ by 
Sawant et al. [1]. The authors investigated if NLR, 
as an all-cause mortality outcome predictor, could 
be utilized alone, and in combination with current 
standardized cardiac risk score models, improved 
the prediction of subsequent short and long-term 
all-cause mortality. They concluded that the NLR 
based on an optimal cut-off value of 7.4 was an ex-
cellent predictor of short- and long-term survival in 
patients with revascularized STEMI and warrants 
larger scale multi-center prospective evaluation, 
as a prognostic indicator. NLR offers improved 
prognostic capacity when combined with conven-
tional clinical scoring systems, such as the TIMI 
risk score. We would like to thank to the authors 
for their contribution.
The pathogenesis of atherosclerosis is mul-
tifactorial; however, it is mostly considered an 
inflammatory condition [2]. Atherosclerotic dis-
eases, especially STEMI, are of high mortality 
and morbidity rates in the world. Previous data 
demonstrated that elevated levels of inflamma-
tory molecules indicate an increased risk of the 
progression of atherosclerosis [3]. The complete 
blood count (CBC) is one of the most frequently 
ordered laboratory tests in clinical practice. Various 
studies have evaluated the performance of these 
hematological CBC parameters to predict disease 
severity and mortality risk. White blood cell count 
and its subtypes including NLR can be easily used 
as inflammatory biomarkers in clinical practice 
[3, 4]. We consider the associations between the 
NLR and a vascular disease and its associated risk 
factors. The NLR can be affected by atheroscle-
rotic risk factors, such as hypercholesterolemia, 
metabolic syndrome, diabetes, and hypertension. 
Importantly, it can predict mortality in cardiovas-
cular diseases. There are also reports of a positive 
correlation between the NLR and commonly used 
inflammatory markers. In addition, inflammatory 
diseases like Behçet’s disease (BD) and psoriasis 
are associated with inflammatory markers [5]. In 
context, the NLR may use activity marker for BD 
patients. We have shown that NLR levels were 
significantly higher in active BD patients compared 
with inactive patients [6].
In conclusion, NLR is an easy method to assess 
inflammation and it may be useful in prognostic 
indicator of many conditions. However, NLR alone, 
without other inflammatory markers, may not 
give information to clinicians about the short- or 
long-term survival in patients with revascularized 
STEMI. Therefore, we think that it should be 
evaluated together with other serum inflamma-
tory markers.
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